Maze Therapeutics, Inc.
MAZE
$14.27
$0.9587.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.68M | -32.79M | -29.58M | -24.75M | 139.06M |
| Total Depreciation and Amortization | 649.00K | 684.00K | 705.00K | 788.00K | 854.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.02M | 4.01M | 5.39M | 5.99M | 2.71M |
| Change in Net Operating Assets | -1.04M | -1.43M | 1.03M | -5.23M | 2.43M |
| Cash from Operations | -30.05M | -29.52M | -22.45M | -23.21M | 145.05M |
| Capital Expenditure | -393.00K | -299.00K | -605.00K | -103.00K | -160.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -393.00K | -299.00K | -605.00K | -103.00K | -160.00K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 259.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 612.00K | 127.88M | 63.00K | 226.00K | 79.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 70.79M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -500.00K | -594.00K | -2.38M | -184.00K |
| Cash from Financing | 612.00K | 127.38M | 70.26M | -2.15M | 154.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.83M | 97.56M | 47.21M | -25.46M | 145.04M |